Insulin Pump

CMS announced proposed new changes that could expand Medicare coverage for continuous glucose monitors and insulin pumps, according to an agency press release.

In this issue, Susan Weiner, MS, RDN, CDN, CDCES, FADCES, talks with nurse practitioner and diabetes care and education specialist Colleen Miller-Owen, MSN, APRN, CDCES, about the benefits of smart insulin pens for multiple daily injections.

An automated decision support tool for optimizing insulin pump settings was noninferior to intensive insulin titration provided by physicians from specialized academic diabetes centers, according to data from a randomized controlled trial.

Good skin care and proper use of wearable diabetes technology can help prevent skin issues related to insulin pump or continuous glucose monitor use, according to two speakers.

People with diabetes reported identifying and treating “low” and “hypo” at relatively high blood glucose levels, and that symptoms of hypoglycemia changed over time, according to survey results.

UnitedHealthcare will now cover Tandem Diabetes’ insulin pumps in network, a reversal of a previous policy that limited pump choices for adults and children with diabetes.

In June, the FDA approved burosumab for a second rare bone disease, expanded the indication for an interoperable insulin pump, cleared an integrated continuous glucose monitor, and approved a biosimilar and a new faster-acting insulin. 

A substantial percentage of youths and young adults with diabetes in the U.S. are not achieving recommended glycemic outcomes despite newer therapies and greater availability of diabetes technology, according to SEARCH study data.

The FDA cleared an expanded pediatric indication for the t:slim X2 interoperable insulin pump, lowering its indicated age for use in children from age 14 years to age 6 years, according to a press release from Tandem.

Among users of a flash glucose monitoring system, rates of diabetic ketoacidosis dropped by 52% for those with type 1 diabetes and by 47% for those with type 2 diabetes, according to data from the RELIEF study.